bpc-157 regulatory fda warning FDA's Overreach on Compounded Peptides FDA panel narrowly backs unapproved

FDA panel narrowly backs unapproved peptide drugs NBC4 Washington FDA Votes in Favor of Peptides After Lengthy Deliberation Drug Topics The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link A health warning about unregulated peptides has been issued by Australia's drug regulator but doctors say more action is needed. Reporting by national health equity reporters Caitlyn Gribbin and Rachel Carbonell, ABC

SKU: 52279227077 · From equiscorp.hu